Key facts
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for LENZ THERAPEUTICS, INC. Common Stock, $0.00001 par value per share (LENZ).
- Disclosed ownership: 14%.
- Date of event: 05 Nov 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 14% | 4,265,106 | 0 | 4,265,106 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | 0001346824 |
| Peter Kolchinsky | 14% | 4,265,106 | 0 | 4,265,106 | /s/ Peter Kolchinsky | Peter Kolchinsky | 0001384859 |
| Rajeev Shah | 14% | 4,265,106 | 0 | 4,265,106 | /s/ Rajeev Shah | Rajeev Shah | 0001619841 |
| RA Capital Healthcare Fund, L.P. | 11% | 3,373,921 | 0 | 3,373,921 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001315082 |
CIK / CUSIP context first